BioCatalystWatch
TGTXWorkspace / TGTX / OverviewCompany library
TG THERAPEUTICS, INC. logo

TG THERAPEUTICS, INC.

TG THERAPEUTICS, INC. (TGTX)

Website

Price
Market cap
Next catalystExpected 2026BRIUMVI (ublituximab-xiiy) · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

azer-cel

Cell therapy

Upcoming / outlook

BRIUMVI (ublituximab-xiiy)

CD20

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

azer-cel

Cell therapy

Upcoming / outlook

BRIUMVI (ublituximab-xiiy)

CD20

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Other pipelines

azer-cel

CD19

PreINDP1P2P3FilingApproved
azer-cel

Cell therapy

PreINDP1P2P3FilingApproved
cosibelimab (TG-1501)

PD-L1

PreINDP1P2P3FilingApproved

History / paused

CD47 × CD19

PreINDP1P2P3FilingApproved

PI3Kδ × CK1ε

PreINDP1P2P3FilingApproved

PI3Kδ × CK1ε

PI3Kδ × CK1ε

PreINDP1P2P3FilingApproved

PI3Kδ × CK1ε

PI3Kδ × CK1ε

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TGTX PR & News

PR & News

TGTX SEC archive